Year archive

AstraZeneca PLC — 2022 filings

All 252 regulatory filings released by AstraZeneca PLC (AZN) in 2022, sourced directly from the official regulator.

252 Filings

2022 Period

2022 filings (252)

Filing	Released	Lang
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-12-30	English
Director/PDMR Shareholding Director's Dealing	2022-12-30	English
CALQUENCE JAPAN APPROVAL FOR TREATMENT-NAIVE CLL Foreign Filer Report	2022-12-28	English
IMFINZI, IMJUDO APPROVED IN JAPAN FOR 3 CANCERS Foreign Filer Report	2022-12-28	English
Calquence Japan approval for treatment-naïve CLL Regulatory Filings	2022-12-28	English
Imfinzi, Imjudo approved in Japan for 3 cancers Regulatory Filings	2022-12-28	English
IMFINZI APPROVED IN EU FOR BILIARY TRACT CANCER Foreign Filer Report	2022-12-21	English
LYNPARZA APPROVED IN EU FOR PROSTATE CANCER Foreign Filer Report	2022-12-21	English
Lynparza approved in EU for prostate cancer Regulatory Filings	2022-12-21	English
Imfinzi approved in EU for biliary tract cancer Legal Proceedings Report	2022-12-21	English
ENHERTU RECOMMENDED FOR APPROVAL IN THE EU BY CHMP FOR PATIENTS WITH HER2-LOW ME Foreign Filer Report	2022-12-19	English
ENHERTU APPROVED IN THE EU FOR PATIENTS WITH PREVIOUSLY TREATED HER2-POSITIVE AD Foreign Filer Report	2022-12-19	English
IMFINZI PLUS IMJUDO RECOMMENDED FOR APPROVAL IN THE EU BY CHMP FOR THE TREATMENT Foreign Filer Report	2022-12-19	English
UPDATE ON PEARL PHASE III TRIAL OF IMFINZI MONOTHERAPY IN STAGE IV NON-SMALL CEL Foreign Filer Report	2022-12-19	English
FORXIGA CHMP OPINION FOR SYMPTOMATIC CHRONIC HF Foreign Filer Report	2022-12-19	English
Enhertu recommended for EU approval in HER2-low BC Regulatory Filings	2022-12-19	English
Enhertu approved in EU for gastric cancer Regulatory Filings	2022-12-19	English
Imfinzi + Imjudo recommended for approvals in EU Regulatory Filings	2022-12-19	English
Update on Imfinzi PEARL trial Regulatory Filings	2022-12-19	English
Forxiga CHMP opinion for symptomatic chronic HF Regulatory Filings	2022-12-19	English
UPDATE ON US REVIEW OF LYNPARZA PROPEL SNDA Foreign Filer Report	2022-12-15	English
Update on US review of Lynparza PROpel sNDA Legal Proceedings Report	2022-12-15	English
CAPIVASERTIB PFS IN HR-POSITIVE BREAST CANCER Foreign Filer Report	2022-12-08	English
Capivasertib PFS in HR-positive breast cancer Earnings Release Q4 2022	2022-12-08	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-12-01	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2022-12-01	English
Block listing Interim Review Regulatory Filings	2022-12-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-12-01	English
ASTRAZENECA ANNOUNCES SALE OF WEST CHESTER SITE Foreign Filer Report	2022-11-30	English
AstraZeneca announces sale of West Chester site Regulatory Filings	2022-11-30	English
ASTRAZENECA TO ACQUIRE NEOGENE THERAPEUTICS Foreign Filer Report	2022-11-29	English
AstraZeneca to acquire Neogene Therapeutics M&A Activity	2022-11-29	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-11-23	English
Director/PDMR Shareholding Director's Dealing	2022-11-23	English
ENHERTU RECOMMENDED FOR EU APPROVAL IN GASTRIC Foreign Filer Report	2022-11-14	English
IMFINZI RECOMMENDED FOR APPROVAL IN THE EU FOR BTC Foreign Filer Report	2022-11-14	English
LYNPARZA COMBO RECOMMENDED IN THE EU FOR MCRPC Foreign Filer Report	2022-11-14	English
IMFINZI + IMJUDO APPROVED IN US FOR LUNG CANCER Foreign Filer Report	2022-11-14	English
Enhertu recommended for EU approval in gastric Regulatory Filings	2022-11-14	English
Imfinzi recommended for approval in the EU for BTC Legal Proceedings Report	2022-11-14	English
Lynparza combo recommended in the EU for mCRPC Regulatory Filings	2022-11-14	English
Imfinzi + Imjudo approved in US for lung cancer Regulatory Filings	2022-11-11	English
YTD AND Q3 2022 RESULTS Foreign Filer Report	2022-11-10	English
YTD and Q3 2022 Results Earnings Release Q3 2022	2022-11-10	English
Earnings Release 2022 Earnings Release Q3 2022	2022-11-10	English
FDA ADVISORY COMMITTEE RECOMMENDS PT027 IN ASTHMA Foreign Filer Report	2022-11-09	English
FDA Advisory Committee recommends PT027 in asthma Regulatory Filings	2022-11-09	English
BEYFORTUS (NIRSEVIMAB) APPROVED IN EU Foreign Filer Report	2022-11-04	English
Beyfortus (nirsevimab) approved in EU Regulatory Filings	2022-11-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-11-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-11-01	English
CAPIVASERTIB PHASE III TRIAL MET PRIMARY ENDPOINTS Foreign Filer Report	2022-10-26	English
Capivasertib Phase III trial met primary endpoints Regulatory Filings	2022-10-26	English
UPDATE ON MESSINA PHASE III TRIAL Foreign Filer Report	2022-10-25	English
Update on MESSINA Phase III trial Legal Proceedings Report	2022-10-25	English
IMFINZI + IMJUDO APPROVED IN ADVANCED LIVER CANCER Foreign Filer Report	2022-10-24	English
Imfinzi + Imjudo approved in advanced liver cancer Regulatory Filings	2022-10-24	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-10-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-10-03	English
BOARD COMMITTEE CHANGES Foreign Filer Report	2022-09-30	English
Board Committee Changes Remuneration Information	2022-09-30	English
KOSELUGO APPROVED IN JAPAN FOR NF1 Foreign Filer Report	2022-09-27	English
TEZSPIRE APPROVED IN JAPAN FOR SEVERE ASTHMA Foreign Filer Report	2022-09-27	English
Koselugo approved in Japan for NF1 Regulatory Filings	2022-09-27	English
Tezspire approved in Japan for severe asthma Regulatory Filings	2022-09-27	English
ULTOMIRIS APPROVED IN EU FOR GMG Foreign Filer Report	2022-09-23	English
Ultomiris approved in EU for gMG Regulatory Filings	2022-09-23	English
LYNPARZA APPROVED IN CHINA FOR OVARIAN CANCER Foreign Filer Report	2022-09-22	English
Lynparza approved in China for ovarian cancer Regulatory Filings	2022-09-22	English
TEZSPIRE APPROVED IN THE EU FOR SEVERE ASTHMA Foreign Filer Report	2022-09-21	English
Tezspire approved in the EU for severe asthma Regulatory Filings	2022-09-21	English
EVUSHELD APPROVED IN EU FOR COVID-19 TREATMENT Foreign Filer Report	2022-09-20	English
Evusheld approved in EU for COVID-19 treatment Regulatory Filings	2022-09-20	English
DANICOPAN PHASE III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2022-09-16	English
NIRSEVIMAB RECOMMENDED FOR APPROVAL IN EU BY CHMP Foreign Filer Report	2022-09-16	English
EVUSHELD POSITIVE CHMP OPINION IN EU Foreign Filer Report	2022-09-16	English
Danicopan Phase III trial met primary endpoint Regulatory Filings	2022-09-16	English
Evusheld positive CHMP opinion in EU Regulatory Filings	2022-09-16	English
Nirsevimab recommended for approval in EU by CHMP Regulatory Filings	2022-09-16	English
FORXIGA APPROVED IN CHINA FOR CKD Foreign Filer Report	2022-09-06	English
IMFINZI APPROVED IN US FOR BILIARY TRACT CANCER Foreign Filer Report	2022-09-06	English
Forxiga approved in China for CKD Regulatory Filings	2022-09-05	English
Imfinzi approved in US for biliary tract cancer Regulatory Filings	2022-09-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-09-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-09-01	English
EVUSHELD APPROVED FOR COVID-19 IN JAPAN Foreign Filer Report	2022-08-30	English
Evusheld approved for COVID-19 in Japan Regulatory Filings	2022-08-30	English
FARXIGA REDUCED RISK OF CV DEATH OR WORSENING HF Foreign Filer Report	2022-08-30	English
FARXIGA SHOWS CV MORTALITY BENEFIT ACROSS EF RANGE Foreign Filer Report	2022-08-30	English
Farxiga shows CV mortality benefit across EF range Regulatory Filings	2022-08-30	English
Farxiga reduced risk of CV death or worsening HF Regulatory Filings	2022-08-30	English
ULTOMIRIS APPROVED IN JAPAN FOR GMG Foreign Filer Report	2022-08-25	English
TAGRISSO APPROVED IN JAPAN FOR EARLY LUNG CANCER Foreign Filer Report	2022-08-25	English
LYNPARZA APPROVED IN JAPAN FOR EARLY BREAST CANCER Foreign Filer Report	2022-08-25	English
Ultomiris approved in Japan for gMG Regulatory Filings	2022-08-25	English
Tagrisso approved in Japan for early lung cancer Regulatory Filings	2022-08-25	English
Lynparza approved in Japan for early breast cancer Regulatory Filings	2022-08-25	English
LYNPARZA GRANTED FDA PRIORITY REVIEW FOR PROPEL Foreign Filer Report	2022-08-16	English
Lynparza granted FDA priority review for PROpel Regulatory Filings	2022-08-16	English
ENHERTU IMPROVED PFS IN MBC IN DESTINY-BREAST02 Foreign Filer Report	2022-08-15	English
Enhertu improved PFS in mBC in DESTINY-Breast02 Regulatory Filings	2022-08-15	English
ENHERTU APPROVED IN US FOR HER2-MUTANT NSCLC Foreign Filer Report	2022-08-12	English
Enhertu approved in US for HER2-mutant NSCLC Regulatory Filings	2022-08-12	English
ACQUISITION OF TENEOTWO COMPLETED Foreign Filer Report	2022-08-11	English
Acquisition of TeneoTwo completed M&A Activity	2022-08-11	English
ENHERTU APPROVED IN THE US FOR HER2-LOW MBC Foreign Filer Report	2022-08-08	English
Enhertu approved in the US for HER2-low mBC Regulatory Filings	2022-08-08	English
LYNPARZA APPROVED IN EU FOR EARLY BREAST CANCER Foreign Filer Report	2022-08-04	English
Lynparza approved in EU for early breast cancer Regulatory Filings	2022-08-04	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-08-01	English
Director/PDMR Shareholding Director's Dealing	2022-08-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-08-01	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-08-01	English
Director/PDMR Shareholding Director's Dealing	2022-08-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-08-01	English
FORM 6-K Foreign Filer Report	2022-07-29	English
CHAIR SUCCESSION Foreign Filer Report	2022-07-29	English
Chair succession Board/Management Information	2022-07-29	English
Half-year Report Interim / Quarterly Report H1 2022	2022-07-29	English
Interim / Quarterly Report 2022 Interim / Quarterly Report H1 2022	2022-07-29	English
TEZSPIRE RECOMMENDED FOR EU APPROVAL IN ASTHMA Foreign Filer Report	2022-07-25	English
ULTOMIRIS RECOMMENDED FOR EU APPROVAL FOR GMG Foreign Filer Report	2022-07-25	English
ENHERTU GRANTED PRIORITY REVIEW FOR HER2-LOW MBC Foreign Filer Report	2022-07-25	English
Tezspire recommended for EU approval in asthma Regulatory Filings	2022-07-25	English
Ultomiris recommended for EU approval for gMG Regulatory Filings	2022-07-25	English
Enhertu granted Priority Review for HER2-low mBC Regulatory Filings	2022-07-25	English
ENHERTU APPROVED IN EU FOR HER2-POSITIVE MBC Foreign Filer Report	2022-07-19	English
Enhertu approved in EU for HER2-positive mBC Regulatory Filings	2022-07-19	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-07-08	English
ASTRAZENECA TO ACQUIRE TENEOTWO AND T CELL ENGAGER Foreign Filer Report	2022-07-05	English
AstraZeneca to acquire TeneoTwo and T cell engager Regulatory Filings	2022-07-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-07-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-07-01	English
IMFINZI IMPROVED PCR IN RESECTABLE LUNG CANCER Foreign Filer Report	2022-06-30	English
Imfinzi improved pCR in resectable lung cancer Regulatory Filings	2022-06-30	English
ANNUAL REPORT Regulatory Filings	2022-06-29	English
ENHERTU RECOMMENDED FOR BREAST CANCER EU APPROVAL Foreign Filer Report	2022-06-27	English
LYNPARZA RECOMMENDED IN EU FOR EARLY BREAST CANCER Foreign Filer Report	2022-06-27	English
Enhertu recommended for breast cancer EU approval Regulatory Filings	2022-06-27	English
Lynparza recommended in EU for early breast cancer Regulatory Filings	2022-06-27	English
EPLONTERSEN PH III TRIAL MET CO-PRIMARY ENDPOINTS Foreign Filer Report	2022-06-21	English
Eplontersen Ph III trial met co-primary endpoints Regulatory Filings	2022-06-21	English
AstraZeneca PLC;AstraZeneca Finance LLC - Base prospectus (debt) Capital/Financing Update	2022-06-17	English
Delisting Announcement 2022 Delisting Announcement	2022-06-10	English
Delisting Announcement 2022 Delisting Announcement	2022-06-09	English
ENHERTU EFFICACY RESULTS IN HER2-LOW BREAST CANCER Foreign Filer Report	2022-06-06	English
Enhertu efficacy results in HER2-low breast cancer Earnings Release Q2 2022	2022-06-06	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2022-06-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-06-01	English
Block listing Interim Review Regulatory Filings	2022-06-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-06-01	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-05-20	English
Director/PDMR Shareholding Director's Dealing	2022-05-20	English
APPOINTMENT OF JOINT CORPORATE BROKERS Foreign Filer Report	2022-05-09	English
Appointment of joint corporate brokers Regulatory Filings	2022-05-09	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-05-06	English
Director/PDMR Shareholding Director's Dealing	2022-05-06	English
ENHERTU APPROVED IN US FOR 2L HER2+ BREAST CANCER Foreign Filer Report	2022-05-05	English
FARXIGA HFPEF PHASE III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2022-05-05	English
ULTOMIRIS NMOSD PH. III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2022-05-05	English
Enhertu approved in US for 2L HER2+ breast cancer Regulatory Filings	2022-05-05	English
Farxiga HFpEF Phase III trial met primary endpoint Regulatory Filings	2022-05-05	English
Ultomiris NMOSD Ph. III trial met primary endpoint Regulatory Filings	2022-05-05	English
IMFINZI COMBO GRANTED PRIORITY REVIEW FOR BTC Foreign Filer Report	2022-05-04	English
Imfinzi combo granted Priority Review for BTC Legal Proceedings Report	2022-05-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-05-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-05-03	English
RESULT OF AGM Foreign Filer Report	2022-04-29	English
Result of AGM AGM Information	2022-04-29	English
Special Business Approved at AGM AGM Information	2022-04-29	English
ASTRAZENECA PLANS NEW R&D CENTRE IN MASSACHUSETTS Foreign Filer Report	2022-04-29	English
FIRST QUARTER 2022 RESULTS Foreign Filer Report	2022-04-29	English
AstraZeneca plans new R&D centre in Massachusetts Legal Proceedings Report	2022-04-29	English
First quarter 2022 results Earnings Release Q1 2022	2022-04-29	English
Earnings Release 2022 Earnings Release Q1 2022	2022-04-29	English
ULTOMIRIS APPROVED IN THE US FOR ADULTS WITH GMG Foreign Filer Report	2022-04-28	English
Ultomiris approved in the US for adults with gMG Regulatory Filings	2022-04-28	English
ENHERTU GRANTED BTD FOR HER2-LOW BREAST CANCER Foreign Filer Report	2022-04-27	English
Enhertu granted BTD for HER2-low breast cancer Regulatory Filings	2022-04-27	English
TREMELIMUMAB US PRIORITY REVIEW FOR IMFINZI COMBO Foreign Filer Report	2022-04-25	English
Tremelimumab US Priority Review for Imfinzi combo Regulatory Filings	2022-04-25	English
ENHERTU GRANTED PRIORITY REVIEW FOR HER2M NSCLC Foreign Filer Report	2022-04-19	English
Enhertu granted Priority Review for HER2m NSCLC Legal Proceedings Report	2022-04-19	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-04-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-04-01	English
ONDEXXYA APPROVED IN JAPAN FOR FXAI REVERSAL Foreign Filer Report	2022-03-29	English
Ondexxya approved in Japan for FXai reversal Regulatory Filings	2022-03-29	English
EVUSHELD APPROVED IN THE EU FOR COVID-19 Foreign Filer Report	2022-03-28	English
Evusheld approved in the EU for COVID-19 Regulatory Filings	2022-03-28	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-03-25	English
Director/PDMR Shareholding Director's Dealing	2022-03-25	English
EVUSHELD POSITIVE EU CHMP OPINION Foreign Filer Report	2022-03-24	English
Evusheld Positive EU CHMP Opinion Regulatory Filings	2022-03-24	English
UPDATE ON CALLA PHASE III TRIAL OF CONCURRENT USE OF IMFINZI AND CHEMORADIOTHERA Foreign Filer Report	2022-03-24	English
Update on CALLA Phase III trial for Imfinzi Regulatory Filings	2022-03-24	English
NOTICE OF AGM Foreign Filer Report	2022-03-23	English
FORM 6-K Foreign Filer Report	2022-03-23	English
Notice of AGM Report Publication Announcement	2022-03-23	English
Proposed Extension of Sharesave Scheme Share Issue/Capital Change	2022-03-23	English
Proxy Form AGM Information	2022-03-23	English
Notice of Annual General Meeting AGM Information	2022-03-23	English
SETTLEMENT OF PATENT LITIGATION FOR ULTOMIRIS Foreign Filer Report	2022-03-17	English
Settlement of patent litigation for Ultomiris Regulatory Filings	2022-03-17	English
LYNPARZA APPROVED IN US FOR EARLY BREAST CANCER Foreign Filer Report	2022-03-14	English
UPDATE ON US REVIEW OF FASENRA IN NASAL POLYPS Foreign Filer Report	2022-03-14	English
Lynparza approved in US for early breast cancer Regulatory Filings	2022-03-14	English
Update on US review of Fasenra in nasal polyps Regulatory Filings	2022-03-14	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-03-09	English
Director/PDMR Shareholding Director's Dealing	2022-03-09	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-03-07	English
Director/PDMR Shareholding Director's Dealing	2022-03-07	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-03-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-03-01	English
Director/PDMR Shareholding Director's Dealing	2022-03-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-03-01	English
ASTRAZENECA AND NEURIMMUNE CLOSE DEAL FOR NI006 Foreign Filer Report	2022-03-01	English
AstraZeneca and Neurimmune close deal for NI006 M&A Activity	2022-03-01	English
FILING OF FORM 20-F WITH SEC Foreign Filer Report	2022-02-23	English
Filing of Form 20-F with SEC Report Publication Announcement FY 2021	2022-02-23	English
IRANNOTICE Regulatory Filings	2022-02-22	English
FORM 20F Annual Report FY 2021	2022-02-22	English
CHAIR SUCCESSION PLANNING UPDATE AND ANNUAL REPORT Foreign Filer Report	2022-02-22	English
ENHERTU IMPROVES PFS AND OS IN HER2-LOW BC Foreign Filer Report	2022-02-22	English
Chair succession planning update and Annual Report Board/Management Information	2022-02-22	English
AZ - 2021 ESEF Annual report-T01 Annual Report (ESEF) FY 2021	2022-02-22	English
AZ - 2021 ESEF Annual report-T01 Annual Report FY 2021	2022-02-22	English
Annual Report 2021 Annual Report FY 2021	2022-02-22	English
Enhertu improves PFS and OS in HER2-low BC Regulatory Filings	2022-02-21	English
SAPHNELO APPROVED IN EU FOR SLE Foreign Filer Report	2022-02-16	English
Saphnelo approved in EU for SLE Regulatory Filings	2022-02-16	English
LYNPARZA COMBO DELAYS PROGRESSION RISK IN PROSTATE Foreign Filer Report	2022-02-15	English
Lynparza combo delays progression risk in prostate Earnings Release Q1 2022	2022-02-15	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2022-02-11	English
Director/PDMR Shareholding Director's Dealing	2022-02-11	English
AZN: FULL YEAR AND Q4 2021 RESULTS Foreign Filer Report	2022-02-10	English
AZN: Full year and Q4 2021 results Earnings Release FY 2021	2022-02-10	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-02-07	English
SEC SCHEDULE 13G Major Shareholding Notification	2022-02-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-02-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-02-01	English
IMFINZI IMPROVES SURVIVAL IN BILIARY TRACT CANCER Foreign Filer Report	2022-01-19	English
IMFINZI COMBO SHOWS UNPRECEDENTED SURVIVAL IN HCC Foreign Filer Report	2022-01-19	English
Imfinzi improves survival in biliary tract cancer Earnings Release Q3 2021	2022-01-19	English
Imfinzi combo shows unprecedented survival in HCC Legal Proceedings Report	2022-01-19	English
ENHERTU GRANTED PRIORITY REVIEW FOR BREAST CANCER Foreign Filer Report	2022-01-18	English
Enhertu granted Priority Review for breast cancer Regulatory Filings	2022-01-17	English
ASTRAZENECA AND NEURIMMUNE SIGN DEAL FOR NI006 Foreign Filer Report	2022-01-07	English
AstraZeneca and Neurimmune sign deal for NI006 Regulatory Filings	2022-01-07	English
TRANSFER OF RIGHTS TO EKLIRA, DUAKLIR COMPLETED Foreign Filer Report	2022-01-05	English
Transfer of rights to Eklira, Duaklir completed M&A Activity	2022-01-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2022-01-04	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2022-01-04	English

Filings by year

2026 85 filings
2025 244 filings
2024 214 filings
2023 196 filings
2022 252 filings
2021 318 filings
2020 306 filings
2019 250 filings
2018 226 filings
2017 189 filings
2016 207 filings
2015 192 filings
2014 352 filings
2013 195 filings
2012 42 filings
2011 19 filings
2010 17 filings